← All Chemed CORP filings

Chemed CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
CHE
Chemed CORP
10-K: Chemed Reports 2025 Profit Decline Amid Rising Costs
Chemed Corporation's 2025 annual report reveals a 12.2% drop in net income and a 7.7% decrease in diluted EPS, despite a 4.1% increase in consolidated service revenues, driven by higher Medicare cap liability and operational expenses.
NYSE
CHE
Chemed CORP
10-K/A: Chemed Corporation Amends 2024 Annual Report to Correct Equity Compensation Plan Information
Chemed Corporation files an amendment to its 2024 annual report to correct the number of securities available for future issuance under equity compensation plans.
NYSE
CHE
Chemed CORP
10-K: Chemed Corporation's 10-K Filing Reveals Financial Performance and Strategic Outlook for 2024
Chemed Corporation's 2024 10-K filing highlights the company's financial performance, business segments, risk factors, and future outlook, with a focus on its VITAS and Roto-Rooter operations.
NYSE
CHE
Chemed CORP
10-K: Chemed Corporation Files 2023 Annual Report on Form 10-K
Chemed Corporation has filed its annual report on Form 10-K for the fiscal year ended December 31, 2023, detailing its financial performance and business activities.